SMARCC1-DOCK3 Fusion FISH Probe
The SMARCC1-DOCK3 Fusion FISH Probe is used to confirm a fusion of the SMARCC1 and DOCK3 genes. The fusion of the SMARCC1 and DOCK3 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SMARCC1-DOCK3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SMARCC1-DOCK3-20-AQAQ | 20 (40 μL) | 200 μL |
|
DOCK3 Gene Summary
This gene is specifically expressed in the central nervous system (CNS). It encodes a member of the DOCK (dedicator of cytokinesis) family of guanine nucleotide exchange factors (GEFs). This protein, dedicator of cytokinesis 3 (DOCK3), is also known as modifier of cell adhesion (MOCA) and presenilin-binding protein (PBP). The DOCK3 and DOCK1, -2 and -4 share several conserved amino acids in their DHR-2 (DOCK homology region 2) domains that are required for GEF activity, and bind directly to WAVE proteins [Wiskott-Aldrich syndrome protein (WASP) family Verprolin-homologous proteins] via their DHR-1 domains. The DOCK3 induces axonal outgrowth in CNS by stimulating membrane recruitment of the WAVE complex and activating the small G protein Rac1. This gene is associated with an attention deficit hyperactivity disorder-like phenotype by a complex chromosomal rearrangement. [provided by RefSeq, Aug 2010]
Gene Name: Dedicator Of Cytokinesis 3
Chromosome: CHR3: 50712671 -51421629
Locus: 3p21.2
SMARCC1 Gene Summary
The protein encoded by this gene is a member of the SWI/SNF family of proteins, whose members display helicase and ATPase activities and which are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI and contains a predicted leucine zipper motif typical of many transcription factors. [provided by RefSeq, Jul 2008]
Gene Name: SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin Subfamily C Member 1
Chromosome: CHR3: 47627377 -47823405
Locus: 3p21.31
Gene Diseases
The SMARCC1 DOCK3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|